“Navigating AI’s Impact on Life Sciences and Patent Law”

Marshall Gerstein Partner Noah Tilton contributed a column to Life Science Leader discussing artificial intelligence’s impact on the life science industry. With all the benefits of this emerging technology – such as drug discovery, clinical trials, and regulatory compliance – also come challenges for protecting intellectual property.

“AI implementation in life sciences raises various patent law considerations, including patent subject matter eligibility, novelty/obviousness, and sufficiency of disclosure,” Noah wrote in describing the various obstacles innovators may face in protecting their IP.

Read Noah’s solutions in his column in Life Science Leader.